← FDA DRUG APPROVALS

FDA ANDA · ANDA085638

CODEINE, ASPIRIN, APAP FORMULA NO. 4

Sponsor: SCHERER LABS

APPLICATION
ANDA085638
TYPE
ANDA
ORIGINAL APPROVAL
1978-05-10
LATEST ACTION
1978-05-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CODEINE, ASPIRIN, APAP FORMULA NO. 4Discontinued
ACETAMINOPHEN 150MG, ASPIRIN 180MG, CODEINE PHOSPHATE 60MG · CAPSULE · ORAL

Approval history

1978-05-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →